US Stock MarketDetailed Quotes
ETON Eton Pharmaceutical
- 10.500
- +0.470+4.69%
Close Nov 19 16:00 ET
- 10.700
- +0.200+1.90%
Post 16:18 ET
271.28MMarket Cap-50000P/E (TTM)
10.680High10.100Low213.93KVolume10.170Open10.030Pre Close2.23MTurnover0.99%Turnover RatioLossP/E (Static)25.84MShares11.11052wk High16.96P/B227.72MFloat Cap3.03052wk Low--Dividend TTM21.69MShs Float11.110Historical High--Div YieldTTM5.78%Amplitude1.950Historical Low10.402Avg Price1Lot Size
About Eton Pharmaceutical Company
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.
Company Profile
SymbolETON
Company NameEton Pharmaceutical
Listing DateNov 13, 2018
Issue Price6.00
Founded2017
MarketNASDAQ
Employees30
Fiscal Year Ends12-31
Address21925 West Field Parkway,Suite 235
CityDeer Park
ProvinceIllinois
CountryUnited States of America
Zip Code60010-7278
Phone1-847-787-7361
Websitehttp://www.etonpharma.com
Company Executives
- Name
- Position
- Salary
- Sean E. Brynjelsen
- President, Chief Executive Officer and Director
- 1.75M
- David C. Krempa
- Chief Business Officer
- 719.08K
- James R. Gruber
- Chief Financial Officer, Principal Accounting Officer, Treasurer and Secretary
- 785.14K
- Dr. Norbert G. Riedel,PhD
- Chairman of the Board
- 155.50K
- Jennifer McKie Adams
- Independent Director
- 119.10K
- Charles J. Casamento
- Independent Director
- 126.90K
- Paul Victor Maier
- Independent Director
- 129.50K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data